Trinity Biotech plc

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:00:00 26/06/2024 am IST 5-day change 1st Jan Change
2.08 USD -13.69% Intraday chart for Trinity Biotech plc -19.69% -3.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading MT
Trinity Biotech plc to Begin European Pre-Pivotal Trial to Optimize Its Cgm Sensor CI
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading MT
Gamida Cell Names Rory Nealon as Chief Financial Officer CI
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading MT
Trinity Biotech plc Launches Its Continuous Glucose Monitoring Microsite to Showcase Its Innovative & Differentiated Technology CI
European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading MT
Transcript : Trinity Biotech plc, Q1 2024 Earnings Call, May 23, 2024
Trinity Biotech plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading MT
Trinity Biotech plc Receives Substantial Additional Orders for TrinScreen HIV CI
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
Chart Trinity Biotech plc
More charts
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
More about the company
  1. Stock Market
  2. Equities
  3. TRIB Stock
  4. News Trinity Biotech plc
  5. Trinity Biotech Secures Additional Orders For TrinScreen HIV Rapid Test Product